Cascade Completed a New Round of Financing to Accelerate Clinical Research of Primary Research Products for Metabolic Diseases

On August 11, 2023, Cascade officially announced the completion of a new round of financing of 140 million yuan. This round of financing is jointly invested by new investors PWC Capital, Guoke Investment, Huiding Investment, Longpan Investment and Xinyi Investment, and the founding team members of the company continue to make additional investments.